⌘K

Login Start Free

Home/Filings/4/0001213900-18-005618

4//SEC Filing

Hexter Joshua 4

Accession 0001213900-18-005618

CIK 0001176309other

View on SEC.gov Company Profile

Filed

May 6, 8:00 PM ET

Accepted

May 7, 4:51 PM ET

Size

5.4 KB

Accession

0001213900-18-005618

Insider Transaction Report

Form 4

Period: 2018-05-03

ORAMED PHARMACEUTICALS INC.ORMP

COO & CBO

Transactions

Award
Stock option (right to buy)
2018-05-03+30,000→ 30,000 total
Exercise: $6.70Exp: 2028-05-03→ Common Stock (30,000 underlying)

Footnotes (1)

[F1]The Stock Option will vest in 16 equal installments of 1,875 on the last day of each quarter commencing June 30, 2018.

Documents

1 file

4
f4050318hexter_oramedpharm.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001573235

Filing Metadata

Form type: 4
Filed: May 6, 8:00 PM ET
Accepted: May 7, 4:51 PM ET
Size: 5.4 KB

View on SEC.gov